484 related articles for article (PubMed ID: 16293093)
1. Degradable, drug-eluting stents: a new frontier for the treatment of coronary artery disease.
Kohn J; Zeltinger J
Expert Rev Med Devices; 2005 Nov; 2(6):667-71. PubMed ID: 16293093
[TBL] [Abstract][Full Text] [Related]
2. [Position paper on the use of drug eluting stents in coronary heart disease].
Mudra H; Bode C; Grube E; de Haan F; Levenson B; Schuler G; Silber S; ;
Z Kardiol; 2004 May; 93(5):416-22. PubMed ID: 15160279
[No Abstract] [Full Text] [Related]
3. Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.
Ahmed WH
Expert Rev Med Devices; 2007 Mar; 4(2):117-20. PubMed ID: 17359218
[TBL] [Abstract][Full Text] [Related]
4. The future of CART in the era of drug eluting stents: "It's not over until it's over". Counterpoint.
Tripuraneni P
Brachytherapy; 2003; 2(2):74-6. PubMed ID: 15062143
[No Abstract] [Full Text] [Related]
5. XIENCE V everolimus-eluting coronary stent system: a novel second generation drug-eluting stent.
Beijk MA; Piek JJ
Expert Rev Med Devices; 2007 Jan; 4(1):11-21. PubMed ID: 17187467
[TBL] [Abstract][Full Text] [Related]
6. Vascular pathology of drug-eluting stents.
Nakazawa G; Finn AV; Virmani R
Herz; 2007 Jun; 32(4):274-80. PubMed ID: 17607533
[TBL] [Abstract][Full Text] [Related]
7. Drug-eluting stents: from evidence to policy.
Marchetti M
Expert Rev Med Devices; 2004 Sep; 1(1):49-63. PubMed ID: 16293010
[TBL] [Abstract][Full Text] [Related]
8. Regulatory issues facing the development of drug-eluting stents: a US FDA perspective.
Boam AB
Expert Rev Med Devices; 2006 May; 3(3):297-300. PubMed ID: 16681451
[TBL] [Abstract][Full Text] [Related]
9. Drug eluting stents.
Panescu D
IEEE Eng Med Biol Mag; 2004; 23(2):21-3. PubMed ID: 15264463
[No Abstract] [Full Text] [Related]
10. The future of coronary artery radiation therapy--"the CART before the (unbridled) horse!". Point.
Devlin PM
Brachytherapy; 2003; 2(2):73-4. PubMed ID: 15062142
[No Abstract] [Full Text] [Related]
11. [Drug-eluting stents: breakthrough or time bomb].
Lüscher TF; Silber S
Herz; 2007 Jun; 32(4):265-7. PubMed ID: 17607531
[No Abstract] [Full Text] [Related]
12. Drug-eluting stents, restenosis and revascularization.
Ramcharitar S; Gaster AL; Daemen J; Serruys P
Herz; 2007 Jun; 32(4):287-95. PubMed ID: 17607535
[TBL] [Abstract][Full Text] [Related]
13. Drug-eluting coronary stents.
Salam AM; Al Suwaidi J; Holmes DR
Curr Probl Cardiol; 2006 Jan; 31(1):8-119. PubMed ID: 16389102
[TBL] [Abstract][Full Text] [Related]
14. Understanding the drug-eluting stent trials.
Coolong A; Kuntz RE
Am J Cardiol; 2007 Sep; 100(5A):17K-24K. PubMed ID: 17719349
[TBL] [Abstract][Full Text] [Related]
15. Effective and efficient strategies for coronary revascularization in the drug-eluting stent era.
Lepor NE; Madyoon H; Kereiakes D
Rev Cardiovasc Med; 2002; 3 Suppl 5():S38-50. PubMed ID: 12478234
[TBL] [Abstract][Full Text] [Related]
16. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
17. [Absorbable coronary stents. New promising technology].
Erbel R; Böse D; Haude M; Kordish I; Churzidze S; Malyar N; Konorza T; Sack S
Herz; 2007 Jun; 32(4):308-19. PubMed ID: 17607538
[TBL] [Abstract][Full Text] [Related]
18. The road to bioabsorbable stents: reaching clinical reality?
Erne P; Schier M; Resink TJ
Cardiovasc Intervent Radiol; 2006; 29(1):11-6. PubMed ID: 16195840
[TBL] [Abstract][Full Text] [Related]
19. Neointimal formation following drug-eluting stents: physiology, timeline, and the influence of drug delivery systems.
Young JJ
Rev Cardiovasc Med; 2007; 8 Suppl 1():S3-10. PubMed ID: 17401309
[TBL] [Abstract][Full Text] [Related]
20. Current issues in coronary stent technology.
Shedden L; Oldroyd K; Connolly P
Proc Inst Mech Eng H; 2009 Jul; 223(5):515-24. PubMed ID: 19623905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
